Application of knowledge and technologies in the
field of genomics and biotechnology for health
: to foster the competitiveness
of Europe's biotechnology industry in developing
diagnostic, disease prevention and therapeutic tools
that contribute to better and more cost-efficient health care.
: Support for
in which academic and industrial partners
collaborate in multidisciplinary approaches to develop these tools,
using cutting- edge technologies arising from genomic research.
Research Action Headings with linked call topics:
Support will be aimed in particular towards innovative research
in genomic start-ups and research-based SMEs. Project consortia
full participants and make the
visible through clear dissemination and exploitation
and regulatory issues should be taken into account, and experts,
patients, and the public involved and consulted as appropriate,
in an effort to promote socially responsible choices, public acceptance
and an efficient exploitation of the new technologies being developed.
100 Technology Offers stemming from EU Biotechnology RTD results
Today's research for tomorrow's treatments - Cell factory research
projects with clinical relevance, download from
Quality of Life Publications
Human Frontier Science Programme (HFSP)
Considering the Community's interest in the Human Frontier Science Programme (HFSP) and the commonality of objectives with this theme, an annual contribution, which will provide the possibility for non G8 Member States to fully benefit from the programme, will be made available for the whole duration of FP6.
Further information may be had at